Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Jonathan J. Paly"'
Autor:
Eric M. Horwitz, Bradley J. Stish, Randal H. Henderson, Amardeep S. Grewal, Brian J. Davis, Rahul D. Tendulkar, Joseph K. Salama, Elizabeth Handorf, David Carpenter, Neha Vapiwala, Nancy P. Mendenhall, Jonathan J. Paly, Devon J. Godfrey, J. Karen Wong, Carlos Vargas
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Data comparing moderately hypofractionated intensity modulated radiation therapy (IMRT) and proton beam therapy (PBT) are lacking. We aim to compare late toxicity profiles of patients with early-stage prostate cancer treated with moderately h
Autor:
Eric M. Horwitz, David Y.T. Chen, Mark A. Hallman, Alexander Kutikov, Elizabeth Handorf, Aneesh Pirlamarla, Chase C. Hansen, Mengying Deng, Daniel M. Geynisman, Jonathan J. Paly, J. Karen Wong
Publikováno v:
Pract Radiat Oncol
INTRODUCTION: Distinct PSA kinetics have been reported across the breadth of radiation modalities used to definitively treat prostate cancer. This study uses a patient-specific model to characterize and compare ideal PSA kinetics for low- and interme
Autor:
Jonathan J. Paly, H N Yankey, A Pirlamarla, Joshua E. Meyer, T Dougherty, Efrat Dotan, Jeffrey M. Farma, Mengying Deng
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e68-e69
Purpose/objective(s) Reirradiation (RI) can cause significant toxicity. BID-RT is a known regimen for rectal cancer recurrence. PLDR-RT is a promising alternative in which doses are delivered in pulses of small doses, with an effective rate of 0.07 G
Autor:
Eric M. Horwitz, Nina Burbure, Brian L. Egleston, Mark L. Sobczak, David Y.T. Chen, J.K. Wong, Shelly B. Hayes, Jonathan J. Paly, Mark A. Hallman
Publikováno v:
American journal of clinical oncology. 44(4)
Purpose We sought to compare changes in patient-reported quality of life (PRQOL) following stereotactic body radiation therapy (SBRT), high dose rate (HDR), and low dose rate (LDR) brachytherapy for prostate cancer. Materials and methods Internationa
Autor:
B. Li, Claire Dempsey, C. Della Biancia, Raymond Carter, N. Hunthausen, A. Yorke, Fei Yang, Anuja Jhingran, A. Shulman, Jonathan J. Paly
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:S119
PURPOSE/OBJECTIVE(S) Intensity-modulated radiation therapy (IMRT) can significantly enhance patient outcomes compared to 3D-conformal radiotherapy (3D-CRT), yet African patients' access to IMRT is sparse. Limited opportunities for continuing educatio
Autor:
Mark L. Sobczak, A. Kutikov, Eric M. Horwitz, Jonathan J. Paly, David Y.T. Chen, C.C. Hansen, Mengying Deng, Shelly B. Hayes, Mark A. Hallman, J.K. Wong
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e886-e887
Autor:
Joanne W. Jang, Jason A. Efstathiou, James A. Talcott, Michael Drumm, Marek Ancukiewicz, Jonathan J. Paly, Jack A. Clark, Anthony L. Zietman, Andrzej Niemierko
Publikováno v:
Cancer Medicine
Definitive treatment for prostate cancer includes radical prostatectomy (RP), external beam radiation therapy (EBRT), and brachytherapy (BT). The different side effect profiles of these options are crucial factors for patients and clinicians when dec
Autor:
Eric M. Horwitz, Jonathan J. Paly
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 107:865-866
Autor:
Clair J. Beard, Phillip J. Gray, Ahmedin Jemal, Chun Chieh Lin, Jason A. Efstathiou, Helmneh M. Sineshaw, Christopher L. Hallemeier, Jonathan J. Paly
Publikováno v:
Practical Radiation Oncology. 6:e249-e258
Disease-specific survival for testicular seminoma approaches 100%, even for those with node-positive disease. We sought to describe modern practice patterns, survival outcomes, and factors associated with postoperative therapy for patients with clini
Autor:
Sebathu Chiyapo, J. Cloete, Michael Drumm, Alec Eidelman, R.H. Clayman, Joseph Kasese, O. John, Dawn Balang, Jonathan J. Paly, Jason A. Efstathiou, David P. Gierga, Scott Dryden-Peterson, R.O. Strauss, M. Nsingo, Bruce A. Chabner, I. Nkele
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e402